Name | (2E,10E,12E,16Z,18E)-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15,17-hexamethyl-19-(3-methyl-6-oxo-2,3-dihydropyran-2-yl)-8-oxononadeca-2,10,12,16,18-pentaenoic acid |
---|
Description | Kazusamycin B is an antibiotic that could be isolated from the fermentation broth of Streptomyces sp. No. 81-484. Kazusamycin B inhibits cell growth and arrests cell cycle at G1 phase. Kazusamycin B can be used in research of cancer[1][2]. |
---|---|
Related Catalog | |
In Vitro | Kazusamycin B (PD 124895; 5 ng/mL; 24 h; 1210 cells) 具有时间依赖性的细胞毒性,使细胞周期停滞在 G1 期[2]。 Kazusamycin B (5-50 ng/mL; 0-6 h; 1210 cells) 适度抑制 RNA 合成,但特异性抑制 2 小时[2]。 Cell Cycle Analysis[2] Cell Line: 1210 cells Concentration: 5 ng/mL Incubation Time: 24 h Result: Arrested cell cycle at G1 phase at 4 hours. |
References |
Density | 1.118g/cm3 |
---|---|
Boiling Point | 754.2ºC at 760 mmHg |
Molecular Formula | C32H46O7 |
Molecular Weight | 542.70 |
Flash Point | 236.5ºC |
Exact Mass | 542.32400 |
PSA | 121.13000 |
LogP | 5.36700 |
Vapour Pressure | 2.96E-26mmHg at 25°C |
Index of Refraction | 1.554 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|